Stocks
Lantheus Holdings, Inc.LNTH
NASDAQHealthcareBiotechnology$79.49-1.16%
A leading developer and manufacturer of diagnostic imaging agents and products, Lantheus Holdings specializes in innovative solutions for the detection and treatment of cardiovascular diseases and cancer. The company's portfolio includes contrast agents, radiopharmaceuticals, and medical devices used in ultrasound and nuclear medicine. Investors monitor LNTH for its growth in precision diagnostics and targeted radiotherapeutics in an expanding global market.
Market Cap: $5.3B52W Range: $47.25 – $108.91
Congressional Interest in Lantheus Holdings, Inc. (LNTH)
1 member of Congress has disclosed 4 trades in Lantheus Holdings, Inc. (LNTH), a Healthcare company. The buy/sell breakdown shows 4 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
4
Sells
0
Who in Congress Is Trading LNTH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-01-28 | Gilbert Cisneros | buy | $1K – $15K |
| 2025-01-13 | Gilbert Cisneros | buy | $1K – $15K |